Relevance of a One-Year Maintenance Therapy with Interleukin-2 in the Treatment of Childhood Acute Myeloid Leukemia: Results from the French Multicenter, Phase III, Randomized Controlled Sfce Trial, ELAM02
暂无分享,去创建一个
A. Baruchel | G. Leverger | A. Rousseau | T. Leblanc | Y. Bertrand | N. Dastugue | W. Cuccuini | O. Fenneteau | V. Gandemer | G. Michel | S. Ducassou | B. Nelken | A. Auvrignon | A. Petit | M. Cachanado | M. Pasquet | H. Lapillonne | C. Ragu